Jump to content

Nina Babel: Difference between revisions

Edit links
From Wikipedia, the free encyclopedia
Next edit →
Content deleted Content added
VisualWikitext
←Created page with 'thumb|Nina Babel, 2023 '''Nina Babel''' is a German physician and scientist. As a professor at Ruhr University Bochum and Charité, she treats patients and performs research in the field of immunodeficiencies and kidney diseases. == Life == Babel is the head of a research group focusing on immunology at the Charité.<ref>{{Cite web |date=22 October 2021 |title=Das Nachbeben der C...'
(No difference)

Revision as of 09:29, 12 March 2024

Nina Babel, 2023

Nina Babel is a German physician and scientist. As a professor at Ruhr University Bochum and Charité, she treats patients and performs research in the field of immunodeficiencies and kidney diseases.

Life

Babel is the head of a research group focusing on immunology at the Charité.[1] At Ruhr University Bochum, she heads the Center for Translational Medicine with a focus on immunology and transplantation at Marien Hospital Herne.[2][3]

She studied medicine at Humboldt University of Berlin and completed her clinical training in the field of internal medicine, nephrology, and immunology at the Charité, where she also obtained her habilitation in 2008.[4] As a Rahel Hirsch habilitation grant recipient, she carried out most of her habilitation work at the Charité and, from 2006 to 2007, as a fellow at the Taussig Cancer Center, Cleveland Clinic (Ohio).[5][6]

Research and patient care

Babel's laboratory investigates mechanisms underlying the immunopathogenesis of viral diseases and develops new parameters and technologies to monitor the individual immune response and the risk of viral infection and virus-associated complications in immunocompromised patients.[4]

Babel has led several research projects focusing on the host's immune response to SARS-CoV-2. For instance, the researchers discovered that individuals who had a severe course of COVID-19 did not exhibit a diminished immune response in comparison to those who had a mild course of the disease.[7] In another study, it was observed that the development of antibodies after vaccination was lower with immunosuppressants than without, while the cellular immune response was preserved. According to this, patients can benefit from the vaccination despite their immunosuppressive therapy.[8] Babel continues to work on the topics of Sars-CoV-2 immunity, and in particular Long Covid and chronic fatigue.[9][10] Furthermore, her research topic includes analysis of interaction between host's immune response and herpes viruses such as Epstein–Barr virus.[11]

Babel has been coordinator and principal investigator of several DFG[12] and BMBF projects.[13][14] She has an h-index of 52, has been involved in over 300 scientific publications,[15][16] and is editor-in-chief for the Immunosuppression section of the journal Frontiers of Transplantation.[17]

Young researchers support programs

Babel works on programs to support young researchers. After serving as co-spokesperson of the SFB 650 Research Training Group at Charité from 2012 to 2016, she continued her work at Ruhr University Bochum, where she heads the RIMUR Research Training Group.[18][19] She also heads the Clinician Scientist Program at Ruhr University Bochum, for which she received funding from the DFG in summer 2022.[20][21]

Publications (selection)

References

  1. ^ "Das Nachbeben der COVID-19-Pandemie und Genomdaten für die Globale Gesundheit: BIH diskutiert auf dem World Health Summit". Health Capital (in German). 22 October 2021. Retrieved 8 January 2024.
  2. ^ "Neue Therapieansätze gegen Osteoporose". Lokalkompass (in German). 13 November 2017. Retrieved 8 January 2024.
  3. ^ "Transplantationspatienten sind durch Corona besonders gefährdet". Westdeutsche Allgemeine Zeitung (in German), p. 12. 20 May 2022.
  4. ^ a b "Prof. Dr. Nina Babel". World Health Summit. Retrieved 8 January 2024.
  5. ^ "e:Med Meeting 2017" (PDF). Systems Medicine. 21 November 2017. Retrieved 8 January 2024.
  6. ^ "Curriculum Vitae" (PDF). Retrieved 8 January 2024.
  7. ^ "Coronavirus: Forscher aus Bochum und Essen überraschen mit Studie zur Immunität". Come-on (in German). 8 September 2020. Retrieved 8 January 2024.
  8. ^ "Corona & Rheuma: Schützt eine Impfung auch Rheumapatienten?". Lokalkompass (in German). 2 November 2022. Retrieved 8 January 2024.
  9. ^ Seibert, Felix S.; Stervbo, Ulrik; Wiemers, Lea; Skrzypczyk, Sarah; Hogeweg, Maximillian; Bertram, Sebastian; Kurek, Julia; Anft, Moritz; Westhoff, Timm H.; Babel, Nina (November 2023). Severity of neurological Long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors. Vol. 22. Autoimmunity Reviews. p. 103445. doi:10.1016/j.autrev.2023.103445. ISSN 1873-0183. PMID 37689093.
  10. ^ Steiner, Sophie; Fehrer, Annick; Hoheisel, Friederike; Schoening, Simon; Aschenbrenner, Anna; Babel, Nina; Bellmann-Strobl, Judith; Finke, Carsten; Fluge, Øystein; Froehlich, Laura; Goebel, Andreas; Grande, Bettina; Haas, Johannes-Peter; Hohberger, Bettina; Jason, Leonard A.; Komaroff, Anthony L.; Lacerda, Eliana; Liebl, Max; Maier, Andrea; Mella, Olav; Nacul, Luis; Paul, Friedemann; Prusty, Bhupesh K.; Puta, Christian; Riemekasten, Gabriela; Ries, Wolfgang; Rowe, Peter C.; Sawitzki, Birgit; Shoenfeld, Yehuda; Schultze, Joachim L.; Seifert, Martina; Sepúlveda, Nuno; Sotzny, Franziska; Stein, Elisa; Stingl, Michael; Ufer, Friederike; Veauthier, Christian; Westermeier, Francisco; Wirth, Klaus; Wolfarth, Bernd; Zalewski, Pawel; Behrends, Uta; Scheibenbogen, Carmen (November 2023). Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome – State of the art: Report of the 2nd international meeting at the Charité Fatigue Center. Vol. 22. Autoimmunity Reviews. p. 103452. doi:10.1016/j.autrev.2023.103452. ISSN 1873-0183. PMID 37742748.
  11. ^ "Krebs nach Organtransplantation: Herner Studie ausgezeichnet". Westdeutsche Allgemeine Zeitung (in German). 17 January 2023. Retrieved 19 February 2024.
  12. ^ "DFG fördert zehn weitere Clinician Scientist-Programme an Medizinischen Fakultäten". DFG (in German). 30 June 2022. Retrieved 8 January 2024.
  13. ^ "Charité". Federal Ministry of Education and Research (Germany) (in German). Retrieved 8 January 2024.
  14. ^ "e:Kid: Systemmedizinischer Ansatz zur Personalisierung immunsuppressiver Therapien nach Nierentransplantation". Federal Ministry of Education and Research (Germany) (in German). Retrieved 8 January 2024.
  15. ^ "Nina Babel's research while affiliated with Universitätsklinikum Marienhospital Herne and other places". Research Gate. Retrieved 10 January 2024.
  16. ^ "Nina Babel". Google scholar. Retrieved 8 January 2024.
  17. ^ "Editorial board". Frontiers in Transplantation. Retrieved 8 January 2024.
  18. ^ "Suppression unerwünschter Immunreaktionen". Deutsche Forschungsgemeinschaft (in German). Retrieved 8 January 2024.
  19. ^ "UA Ruhr startet Promotionskolleg RIMUR". MERCUR Mercator Research Centre Ruhr (in German). 27 February 2019. Retrieved 8 January 2024.
  20. ^ "Clinician Scientist Programm der RUB". Ruhr University Bochum. Retrieved 8 January 2024.
  21. ^ "DFG fördert zehn weitere Clinician Scientist-Programme an Medizinischen Fakultäten". Deutsche Forschungsgemeinschaft (in German). 30 June 2022. Retrieved 8 January 2024.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Nina_Babel&oldid=1213320470"